Aliskiren Reduces Myocardial Ischemia–Reperfusion Injury by a Bradykinin B2Receptor– and Angiotensin AT2Receptor–Mediated Mechanism-Reference-Cited by-同舟云学术

Aliskiren Reduces Myocardial Ischemia–Reperfusion Injury by a Bradykinin B2Receptor– and Angiotensin AT2Receptor–Mediated Mechanism

Published:2014-04 Issue:4 Volume:63 Page:768-773
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Koid Suang Suang¹,Ziogas James¹,Campbell Duncan John¹

Affiliation:

1. From St Vincent’s Institute of Medical Research and Department of Medicine (S.S.K., D.J.C.) and Department of Pharmacology and Therapeutics (S.S.K., J.Z.), University of Melbourne, Victoria, Australia.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference49 articles.

1. Summary of AHRQ’s comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease.;White CM;J Manag Care Pharm,2011

2. A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure

3. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary

4. Combined Blockade of the Renin-Angiotensin System With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists

5. Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the crosstalk between renin‐angiotensin system receptors;Acta Physiologica;2024-03-15

2. Protective Biology and Engineering;ASME Open Journal of Engineering;2023-01-01

3. Kinins and Kinin Receptors in Cardiovascular and Renal Diseases;Pharmaceuticals;2021-03-08

4. Peptidomics analysis revealed that a novel peptide VMP‑19 protects against Ang II‑induced injury in human umbilical vein endothelial cells;Molecular Medicine Reports;2021-02-23

5. Differential responses of bone to angiotensin II and angiotensin(1-7): beneficial effects of ANG(1-7) on bone with exposure to high glucose;American Journal of Physiology-Endocrinology and Metabolism;2021-01-01